Related Experiment Videos
Esophageal cancer
1Johns Hopkins Oncology Center, Baltimore, Maryland, USA.
Current Opinion in Oncology
|July 1, 1995
Summary
Esophageal cancer trends are shifting globally, with rising adenocarcinoma rates in the West. Advances in understanding its biology and epidemiology are improving screening, prognosis, and combined-modality treatments for better survival.
Area of Science:
- Gastroenterology and Oncology
- Epidemiology of Cancer
Background:
- Esophageal cancer is prevalent in developing nations, linked to poor nutrition, tobacco, and alcohol.
- Western nations observe an increase in distal esophageal and gastroesophageal junction adenocarcinoma, while squamous cell carcinoma rates are stable.
- Evolving knowledge of esophageal cancer's epidemiology and molecular biology informs clinical practice.
Purpose of the Study:
- To review current understanding of esophageal cancer's epidemiology and molecular biology.
- To discuss advancements in clinical applications for screening and prognosis.
- To highlight the potential of combined-modality therapy for improved patient outcomes.
Main Methods:
- Literature review of recent studies on esophageal cancer.
- Analysis of epidemiological trends and molecular biology insights.
- Evaluation of current treatment strategies, including combined-modality therapy.
Main Results:
- Significant global disparities in esophageal cancer incidence exist.
- A notable epidemiological shift towards adenocarcinoma in Western populations is occurring.
- Combined-modality treatments (chemotherapy, radiation, surgery) show promise for enhanced survival.
Conclusions:
- Further clinical trials are needed to define optimal treatment combinations and surgical techniques.
- Improved understanding of esophageal cancer biology and epidemiology is crucial for effective management.
- Advances in treatment offer hope for better long-term outcomes in esophageal cancer patients.